Humana (HUM) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- -$0.70
- Estimate
- -$1.00
- Surprise
- +30.3%
- Revenue (period 2026-09-30)
- $41.16B
- Score today
- 5.8/10
Revenue source: xbrl.
How the report landed
Humana (HUM) reported a narrower loss than forecast — adjusted EPS of -$0.70 against the -$1.00 estimate (a 30.3% beat on a still-unprofitable quarter).
Coverage in the report window
- Humana FY2026 Revenue expected to be more than $160.000B vs $162.640B Est — benzinga, 2026-11-06
Where TrendMatrix's rating stands now
TrendMatrix currently rates HUM Hold at 5.8/10; no pre/post engine snapshot brackets this report.
4 of the last 4 quarters beat the estimate; this quarter's +30.3% surprise compares with a +10.2% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (4/4)
What argues against it
- Analyst target reached - limited upside remaining
- Near 52-week high (5.0% away)
- V7 low-quality RISK_OFF penalty: -0.5 (Q=4.2)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $433.74
- Stop
- $403.38
The stock trades at 42.3× trailing but 25.4× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: trading volume is running 1.8× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-07 — shown for context, not personalized investment advice.
HUM at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Healthcare Plans
- Market cap
- $52.08B
- P/E (fwd)
- 25.4
- P/E (ttm)
- 42.3
- 52-week range
- $163.11–$456.50
- Off 52-week high
- 5.0%
- RSI (14)
- 63
- Volume vs avg
- 1.83×
- Score today
- 5.8/10